Publication & Citation Trends
Publications
0 total
Abstract 5169: Identification and optimization of pyridylbenzylamine analog 1 as potent and selective Helios degrader
Cited by 0
Semantic Scholar
Development of a ZBTB7A and Wiz Dual Degrading, HbF-Activating CELMoD™ for the Treatment of Sickle Cell Disease
Cited by 3
Semantic Scholar
Metabolomic Profiling and Drug Interaction Characterization Reveal Riboflavin As a Breast Cancer Resistance Protein–Specific Endogenous Biomarker That Demonstrates Prediction of Transporter Activity In Vivo
Cited by 14
Semantic Scholar
Simultaneous measurement of mouse and human albumin in chimeric mice with humanized livers.
Cited by 2
Semantic Scholar
MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesity. OA
Cited by 39
Semantic Scholar
Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis OA
Cited by 18
Semantic Scholar
A peptide immunoaffinity LC-MS/MS strategy for quantifying the GPCR protein, S1PR1 in human colon biopsies. OA
Cited by 3
Semantic Scholar
Research Topics
Metabolomics and Mass Spectrometry Studies
(20)
Mass Spectrometry Techniques and Applications
(15)
Analytical Chemistry and Chromatography
(14)
Drug Transport and Resistance Mechanisms
(9)
Liver Disease Diagnosis and Treatment
(8)
Affiliations
Bristol-Myers Squibb (Germany)
Union Institute & University
Cornell University
Diabetes Australia
LabCorp (United States)